Catalyst
Slingshot members are tracking this event:
FDA Approves Lannett's (LCI) Abbreviated New Drug Application for a Generic Version of Allergan's (AGN) Dementia Medication Namenda
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| LCI |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 14, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Abbreviated New Drug Application, Fda, Approval, Generic, Namenda, Dementia
